Global Scoring Balloon Catheters Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

What is the Scoring Balloon Catheters Market Size and Growth Rate?

• As per Data Bridge Market Research analysis, the scoring balloon catheters market was valued at USD 480.30 million in 2025 and is projected to reach USD 966.19 million by 2033, growing at a CAGR of 9.13% from 2026 to 2033.
• The market is experiencing consistent growth driven by the increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive endovascular procedures, and growing demand for advanced lesion preparation technologies in coronary and peripheral interventions.
• The increasing burden of coronary artery disease (CAD), peripheral artery disease (PAD), and heavily calcified vascular lesions, combined with continuous advancements in interventional cardiology, is encouraging hospitals and cardiac catheterization laboratories to adopt scoring balloon catheters for controlled plaque modification and improved procedural outcomes. Monorail and over-the-wire scoring balloon systems are increasingly being utilized in complex angioplasty procedures, providing enhanced lesion compliance, reduced balloon slippage, and more effective vessel preparation before stent implantation.

Market Size & Forecast

• Global Market Value (2025): USD 480.30 Million
• Expected Market Value (2033): USD 966.19 Million
• Forecast CAGR (2026–2033): 9.13%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia Pacific

What are the Major Takeaways of the Scoring Balloon Catheters Market?

• North America dominated the scoring balloon catheters market with the largest revenue share of 38.10% in 2025, supported by high PCI procedure volumes, advanced interventional cardiology infrastructure, established reimbursement systems, and rapid adoption of lesion preparation technologies
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 9.91% from 2026 to 2033, fueled by expanding interventional cardiology capacity, increasing cardiovascular disease burden, and rising adoption across China, Japan, and India.
• The non-compliant segment led the market with a 58.3% share in 2025, driven by its ability to provide controlled plaque modification while maintaining balloon diameter at high inflation pressures.
• Semi-compliant are the fastest-growing balloon type, projected to register a CAGR of 8.9%, reflecting the surge in use in less complex lesions and peripheral vascular interventions requiring greater balloon flexibility.
• The nylon segment dominated the material category with a 42.5% revenue share in 2025, led by its flexibility, durability, and ability to withstand high inflation pressures while maintaining consistent balloon performance
• Coronary accounted for 35.2% of the market share in 2025, preferred by the high prevalence of coronary artery disease and growing volumes of percutaneous coronary intervention procedures.
• The medium-pressure segment is the fastest-growing inflation pressure category, with a CAGR of 8.4%, driven by increasing utilization in routine coronary and peripheral angioplasty involving moderately complex lesions.

Report Scope and Scoring Balloon Catheters Market Segmentation    

What is the Key Trend in the Scoring Balloon Catheters Market?

• Scoring balloon catheters are increasingly being adopted for controlled plaque modification in complex coronary interventions, particularly for moderate-to-severe calcified lesions where conventional balloon angioplasty may provide inadequate lesion preparation.
• For instance, in July 2024, Catheterization and Cardiovascular Interventions published a comparative study of 38 patients with severely calcified coronary lesions and reported that a novel scoring balloon achieved a significantly greater expansion ratio than a cutting balloon after orbital atherectomy, supporting the growing use of scoring balloons for complex lesion preparation.
• Advanced scoring balloon designs are increasingly focused on improving crossability, flexibility, deliverability, and plaque-modification efficiency while reducing the limitations associated with conventional bulky scoring balloon systems.
• Interventional cardiologists are increasingly combining scoring balloons with other lesion-preparation technologies, including atherectomy and drug-coated balloons, to improve vessel expansion and optimize outcomes before definitive treatment.
• For instance, in January 2025, Catheterization and Cardiovascular Interventions published a meta-analysis evaluating modified balloon angioplasty, including scoring balloons, after rotational atherectomy and found improved angiographic outcomes compared with plain-balloon angioplasty before drug-eluting stent implantation, reinforcing the trend toward combination lesion-preparation strategies.
• As the treatment of complex and heavily calcified coronary lesions continues expanding, manufacturers are prioritizing innovative scoring balloon technologies with improved deliverability and controlled plaque modification, strengthening their role in minimally invasive cardiovascular interventions.

What are the Key Drivers of the Scoring Balloon Catheters Market?

• The increasing prevalence of coronary artery disease and vascular calcification is significantly increasing demand for specialized lesion-preparation devices capable of modifying resistant plaques before stent implantation and other interventional procedures.
• For instance, in October 2024, the Journal of the American College of Cardiology published research showing that scoring-balloon lesion preparation improved the efficacy of drug-coated balloon treatment in patients with de novo coronary artery disease, supporting the expanding use of scoring balloons to optimize lesion preparation before drug delivery.
• Hospitals and interventional cardiology centers are increasingly adopting minimally invasive approaches that use scoring balloons to facilitate controlled plaque modification, optimize vessel expansion, and potentially improve procedural efficiency during complex coronary interventions.
• For instance, in July 2024, Clinical Research in Cardiology published a study of six randomized trials involving 648 patients treated with modified balloons for severely calcified coronary lesions, highlighting continued clinical evaluation of scoring and cutting balloons as lesion-preparation technologies before stent implantation.
• With growing clinical emphasis on effective lesion preparation and improved stent expansion, scoring balloon catheters will remain increasingly important for managing complex calcified lesions and supporting minimally invasive cardiovascular treatment strategies globally.

What Factors are Challenging the Growth of the Scoring Balloon Catheters Market?

• Conventional scoring balloon catheters can present challenges related to stiffness, bulkiness, lesion crossing, and navigability, particularly when treating tortuous vessels or severely complex coronary anatomies requiring precise device delivery.
• For instance, in August 2021, EuroIntervention published the ISAR-CALC randomized trial involving 74 patients with severely calcified coronary lesions; the super high-pressure balloon achieved comparable stent expansion to the scoring balloon while producing a larger minimum lumen diameter and lower residual diameter stenosis, highlighting competition from alternative balloon technologies.
• Limited high-quality randomized evidence comparing scoring balloons with alternative lesion-preparation strategies can create uncertainty among clinicians, potentially slowing standardized adoption across different coronary intervention procedures and treatment settings.
• The relatively higher cost of scoring balloon catheters compared with conventional angioplasty balloons can increase procedure expenses, particularly in healthcare systems with constrained reimbursement budgets and limited access to advanced interventional devices.
• For instance, in December 2022, Journal of Invasive Cardiology published an analysis of the FDA MAUDE database covering 248 reported complications associated with the AngioSculpt scoring balloon catheter; device tip breakage accounted for 44.8% and balloon rupture for 26.6% of reported complications, highlighting device durability and failure risks that can restrain adoption.
• The availability of alternative lesion-preparation technologies, including rotational atherectomy, intravascular lithotripsy, and cutting balloons, creates competitive pressure on scoring balloon adoption by providing physicians with multiple options for treating heavily calcified and resistant lesions.

How is the Scoring Balloon Catheters Market Segmented?

The scoring balloon catheters market is segmented on the basis of balloon type, material, diameter, application, inflation pressure, and end use.

• By Balloon Type

On the basis of balloon type, the scoring balloon catheters market is segmented into semi-compliant, non-compliant, and others. The non-compliant segment dominated the market with an estimated 58.3% share in 2025, owing to its ability to provide controlled plaque modification while maintaining balloon diameter at high inflation pressures. These balloons are widely used for calcified and complex coronary lesions requiring precise lesion preparation before stent implantation. Their high-pressure capability supports effective treatment of resistant lesions while limiting uncontrolled balloon expansion. Interventional cardiologists increasingly use non-compliant scoring balloons for challenging lesions and in-stent restenosis procedures. Continuous product improvements focused on crossability and deliverability are further supporting adoption.

The semi-compliant segment is projected to register the fastest growth at an estimated CAGR of 8.9% from 2026 to 2033, driven by increasing use in less complex lesions and peripheral vascular interventions requiring greater balloon flexibility. These balloons conform more readily to vessel anatomy, supporting navigation through tortuous vascular pathways. Their flexibility and trackability make them useful where ease of delivery is particularly important. Rising demand for minimally invasive cardiovascular procedures is supporting their broader adoption. Manufacturers are developing improved semi-compliant designs with enhanced tracking and lesion-crossing capabilities

• By Material

On the basis of material, the scoring balloon catheters market is segmented into nylon, PET, polyurethane, and others. The nylon segment dominated the market with an estimated 42.5% share in 2025, supported by its flexibility, durability, and ability to withstand high inflation pressures while maintaining consistent balloon performance. Nylon provides strong trackability through complex vascular anatomy and supports controlled balloon expansion. Its mechanical properties make it suitable for coronary and peripheral interventions requiring reliable lesion preparation. The material also offers established manufacturing compatibility with specialized catheter designs. Broad clinical acceptance continues to support its use across scoring balloon platforms.

The PET segment is projected to register the fastest growth at an estimated CAGR of 8.6% from 2026 to 2033, driven by increasing demand for high-pressure balloon performance in complex cardiovascular interventions. PET provides high dimensional stability and low compliance, supporting precise balloon expansion during lesion preparation. Its mechanical strength makes it suitable for resistant and calcified lesions requiring controlled dilation. The material is increasingly relevant to advanced scoring balloon designs targeting challenging vascular anatomy. Improvements in polymer engineering are enhancing burst strength and catheter reliability. Growing use of specialty balloons in complex interventions is expected to create additional demand for PET-based products.

• By Diameter

On the basis of diameter, the scoring balloon catheters market is segmented into less than 3 mm, 3–5 mm, and greater than 5 mm. The 3–5 mm segment dominated the market with an estimated 47.8% share in 2025, owing to its broad use in coronary angioplasty and peripheral vascular interventions. This diameter range provides compatibility with a wide variety of vessels encountered during cardiovascular procedures. It enables effective plaque modification while maintaining appropriate vessel compatibility. Hospitals and cardiac catheterization laboratories frequently use these balloon sizes across multiple clinical indications. Continued growth in coronary intervention volumes is supporting sustained demand for this diameter range.

The greater than 5 mm segment is projected to register the fastest growth at an estimated CAGR of 8.8% from 2026 to 2033, driven by increasing treatment of peripheral artery disease and larger-diameter vascular lesions. These balloons are increasingly used in femoral, iliac, and other peripheral interventions requiring greater luminal expansion. Rising prevalence of peripheral vascular disease is increasing demand for devices capable of treating larger vessels. Improvements in balloon construction are enhancing procedural safety and performance in larger vessel anatomies. Growing availability of minimally invasive peripheral interventions is supporting wider utilization. Expanding investment in peripheral vascular programs is expected to further accelerate demand for larger-diameter scoring balloons.

• By Application

On the basis of application, the scoring balloon catheters market is segmented into coronary and peripheral. The coronary segment dominated the market with an estimated 35.2% share in 2025, supported by the high prevalence of coronary artery disease and growing volumes of percutaneous coronary intervention procedures. Scoring balloons are widely used to prepare calcified coronary lesions before stent implantation. Their scoring elements enable controlled plaque modification while helping minimize balloon slippage. They can facilitate more effective lesion expansion and subsequent stent deployment. Increasing adoption of minimally invasive cardiovascular procedures is strengthening demand in coronary applications.

The peripheral segment is projected to register the fastest growth at a CAGR of 9.2% from 2026 to 2033, driven by increasing incidence of peripheral artery disease and expanding utilization of endovascular treatment techniques. Scoring balloon catheters are increasingly used for complex femoropopliteal and below-the-knee lesions requiring effective vessel preparation. Growing awareness of minimally invasive peripheral interventions is encouraging greater device adoption. Healthcare providers are also using specialty balloons before drug-coated balloon therapy and stent placement. Product innovation focused specifically on peripheral vascular anatomy is expanding clinical applicability. Increasing cardiovascular disease burden and aging populations are expected to sustain long-term demand for peripheral scoring balloon technologies.

• By Inflation Pressure

On the basis of inflation pressure, the scoring balloon catheters market is segmented into low pressure, medium pressure, and high pressure. The high-pressure segment is estimated to dominate the market with 45% share in 2025, owing to its ability to address resistant and heavily calcified lesions requiring greater radial force. High-pressure scoring balloons support controlled plaque modification while maintaining predictable balloon dimensions during inflation. They are particularly valuable in complex coronary interventions where conventional dilation may be insufficient. Their pressure capability facilitates lesion preparation before stent implantation and other definitive treatments. Increasing prevalence of calcified vascular disease is supporting their utilization across interventional centers.

The medium-pressure segment is projected to register the fastest growth at an estimated CAGR of 8.4% from 2026 to 2033, supported by increasing utilization in routine coronary and peripheral angioplasty involving moderately complex lesions. Medium-pressure balloons provide a balance between effective lesion modification and procedural control. Their pressure characteristics make them suitable for a broad range of interventions where extremely high pressures are unnecessary. Increasing adoption of minimally invasive cardiovascular procedures is supporting demand across hospitals and specialized cardiac facilities. Improvements in balloon materials and inflation consistency are enhancing procedural performance. Expanding cardiovascular treatment capacity in emerging healthcare systems is expected to create additional demand for medium-pressure scoring balloon technologies.

• By End Use

On the basis of end use, the scoring balloon catheters market is segmented into hospitals, cardiac centers, and others. The hospitals segment dominated the market with an estimated 62.1% share in 2025, driven by the concentration of advanced catheterization laboratories, specialized cardiovascular departments, and high procedural volumes. Hospitals perform a substantial proportion of complex coronary and peripheral angioplasty procedures requiring specialty lesion-preparation devices. The availability of experienced interventional cardiologists and comprehensive cardiovascular facilities further supports adoption. Continuous investment in cardiovascular infrastructure is increasing procedural capacity across hospitals. Growing patient preference for advanced cardiovascular care is also strengthening demand.

The cardiac centers segment is projected to register the fastest growth at an estimated CAGR of 9.0% from 2026 to 2033, driven by increasing specialization in minimally invasive cardiovascular procedures and expansion of dedicated interventional cardiac services. Specialized cardiac centers provide focused expertise for complex coronary interventions requiring advanced lesion-preparation technologies. Their concentration of catheterization laboratories and trained specialists supports efficient adoption of specialty balloon devices. Rising healthcare investment and expansion of dedicated cardiac facilities are increasing access to specialized cardiovascular treatment. Growing patient demand for focused and minimally invasive cardiac care is further supporting segment growth. Continued improvements in catheterization technologies and expansion of specialized cardiac infrastructure are expected to sustain the segment's rapid development.

Which Region Holds the Largest Share of the Scoring Balloon Catheters Market?

• North America dominated the scoring balloon catheters market with the largest revenue share of 38.10% in 2025, supported by high PCI procedure volumes, advanced interventional cardiology infrastructure, established reimbursement systems, and rapid adoption of lesion preparation technologies
• The region also benefits from a high prevalence of coronary and peripheral artery diseases, growing use of advanced lesion-preparation technologies, and increasing adoption of scoring balloons for complex and calcified lesions. Rising investments in interventional cardiology and continued technological advancements in catheter-based therapies further strengthen North America's leadership position in the global market.

U.S. Scoring Balloon Catheters Market Insight

The U.S. scoring balloon catheters market is witnessing strong growth due to the rising prevalence of coronary artery disease, increasing adoption of percutaneous coronary interventions, and rapid uptake of advanced lesion preparation technologies. The country's well-established interventional cardiology infrastructure, favorable reimbursement framework, and strong presence of leading medical device manufacturers continue to support market expansion. In addition, growing utilization of minimally invasive cardiovascular procedures and increasing demand for specialty balloons in complex calcified lesions are accelerating product adoption across hospitals and cardiac catheterization laboratories.

Asia-Pacific Scoring Balloon Catheters Market Insight

The Asia-Pacific scoring balloon catheters market is expected to witness rapid growth, driven by the increasing burden of cardiovascular disease, expanding healthcare infrastructure, and rising adoption of minimally invasive coronary interventions across countries such as China, India, and Japan. Growing investments in catheterization laboratories, improving access to advanced cardiovascular therapies, and increasing awareness regarding early diagnosis and treatment are supporting regional market expansion. In addition, rising healthcare expenditure and the growing presence of multinational medical device manufacturers are accelerating adoption of advanced balloon catheter technologies across the region.

Japan Scoring Balloon Catheters Market Insight

The Japan scoring balloon catheters market is witnessing consistent growth due to the country's aging population, increasing prevalence of complex and calcified coronary lesions, and widespread adoption of advanced interventional cardiology procedures. Japanese hospitals are increasingly utilizing specialty balloon technologies to support lesion preparation and improve procedural outcomes in complex coronary interventions. Strong clinical expertise, universal healthcare coverage, and continuous investment in cardiovascular innovation further contribute to market expansion. In addition, the growing adoption of scoring balloons within the country's angioplasty balloon market is supporting sustained demand for specialized lesion-preparation devices.

China Scoring Balloon Catheters Market Insight

The China scoring balloon catheters market is growing rapidly, driven by increasing cardiovascular disease prevalence, expanding hospital infrastructure, and rising adoption of advanced interventional cardiology technologies. Government healthcare reforms, improving access to percutaneous coronary interventions, and increasing investments in cardiovascular centers are significantly boosting demand for specialty balloon catheters. In addition, expanding local medical-device capabilities, growing catheterization infrastructure, and increasing adoption of minimally invasive cardiovascular procedures are strengthening market expansion across China.

U.K. Scoring Balloon Catheters Market Insight

The U.K. scoring balloon catheters market is experiencing steady growth, supported by increasing adoption of minimally invasive cardiovascular procedures, advanced interventional cardiology practices, and specialty balloon technologies for complex lesions. Growing demand for effective lesion preparation before stent placement and drug-coated balloon treatment is contributing to market expansion across hospitals and cardiac centers. Furthermore, continuous advancements in catheter design, increasing focus on improving procedural outcomes, and established healthcare infrastructure are supporting wider adoption of scoring balloon catheters in the U.K.

Germany Scoring Balloon Catheters Market Insight

The Germany scoring balloon catheters market is expanding steadily due to the country's advanced healthcare infrastructure, strong medical-device industry, and increasing adoption of sophisticated interventional cardiology technologies. Hospitals and cardiac centers are increasingly utilizing specialty balloons for complex coronary interventions, calcified lesions, and controlled vessel preparation. Continuous innovation in catheter technologies, strong clinical expertise, and increasing emphasis on minimally invasive cardiovascular treatment are further driving market growth in Germany. The presence of established medical-device manufacturers and advanced cardiovascular care capabilities also supports the country's position as an important European market.

Which are the Top Companies in Scoring Balloon Catheters Market?

The scoring balloon catheters industry is primarily led by well-established companies, including:

• Koninklijke Philips N.V. (Netherlands)
• OrbusNeich Medical Group Holdings Limited (Hong Kong)
• Boston Scientific Corporation (U.S.)
• Abbott (U.S.)
• B. Braun SE (Germany)
• Terumo Corporation (Japan)
• BIOTRONIK SE & Co. KG (Germany)
• Medtronic (Ireland)
• Cardinal Health, Inc. (U.S.)
• Teleflex Incorporated (U.S.)
• Integer Holdings Corporation (U.S.)
• Asahi Intecc Co., Ltd. (Japan)
• BrosMed Medical Co., Ltd. (China)
• Acrostak AG (Switzerland)
• Balton Sp. z o.o. (Poland)
• iVascular S.L.U. (Spain)
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
• Tokai Medical Products Inc. (Japan)
• Kaneka Corporation (Japan)
• NIPRO CORPORATION (Japan)

What are Latest Developments in Scoring Balloon Catheters Market?

• In August 2024, the Australian Therapeutic Goods Administration (TGA) registered Philips Electronics Australia’s AngioSculpt EVO RX PTCA Scoring Balloon Catheter, expanding its regulatory availability in the Australian market. The device was registered as a Class III medical device for coronary angioplasty applications and represents continued international expansion of Philips’ scoring balloon portfolio. This development supports broader access to specialty balloon technologies for complex coronary interventions.
• In February 2024, Clinical Case Reports, published by John Wiley & Sons, reported the successful use of the Aperta NSE scoring balloon with a bending technique to cross a previously implanted stent and treat resistant in-stent restenosis. The report highlighted the scoring balloon’s application in challenging coronary intervention and demonstrated a practical technique for improving device crossing in complex lesions.
• In May 2023, OrbusNeich announced the start of the clinical study of its Scoreflex TRIO high-pressure, three-wire scoring balloon dilatation catheter in China, following its successful use in the country’s first PCI procedure with the device. The procedure involved treatment of severe coronary stenosis and calcification, marking an important step toward obtaining product approval in China. This development highlights continued advancement of high-pressure scoring balloon technologies for complex coronary lesions.
• In January 2022, OrbusNeich announced that the U.S. Food and Drug Administration (FDA) had granted Premarket Approval (PMA) for the Scoreflex NC Scoring PTCA Catheter. The dual-wire scoring system is designed to provide focused-force angioplasty for controlled plaque modification, particularly in resistant and calcified coronary lesions. The approval enabled the company to expand the availability of its scoring balloon technology to U.S. physicians.
• In November 2021, Philips introduced its newly designed AngioSculpt Evo Scoring Balloon Catheter RX at TCT 2021 for coronary artery stenosis, including in-stent restenosis. Philips highlighted design improvements including a smaller tip, hydrophilic coating, laser-cut hypotube, and helical nitinol scoring elements to improve deliverability and controlled lesion modification. The development demonstrated continued innovation in scoring balloon design for complex coronary interventions.